Publicaciones en colaboración con investigadores/as de St George's, University of London (12)

2024

  1. Clinical and neuroradiological spectrum of biallelic variants in NOTCH3

    eBioMedicine, Vol. 107

2023

  1. Causes of death in children with congenital anomalies up to age 10 in eight European countries

    BMJ Paediatrics Open, Vol. 7, Núm. 1

  2. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  3. Ethics and legal requirements for data linkage in 14 European countries for children with congenital anomalies

    BMJ Open, Vol. 13, Núm. 7

2022

  1. Temporal and geographical variations in survival of children born with congenital anomalies in Europe: A multi-registry cohort study

    Paediatric and Perinatal Epidemiology, Vol. 36, Núm. 6, pp. 792-803

  2. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

  2. Signal Detection in EUROmediCAT: Identification and Evaluation of Medication–Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of Reference

    Drug Safety, Vol. 44, Núm. 7, pp. 765-785

2020

  1. Recurrent De Novo NAHR Reciprocal Duplications in the ATAD3 Gene Cluster Cause a Neurogenetic Trait with Perturbed Cholesterol and Mitochondrial Metabolism

    American Journal of Human Genetics, Vol. 106, Núm. 2, pp. 272-279

2016

  1. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 1, pp. 196-207

2012

  1. Mortality after surgery in Europe: A 7 day cohort study

    The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065

2003

  1. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome

    Neurology, Vol. 60, Núm. 11, pp. 1811-1816